Lexeo Therapeutics (LXEO) Free Cash Flow: 2022-2024
Historic Free Cash Flow for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to -$81.6 million.
- Lexeo Therapeutics' Free Cash Flow rose 15.78% to -$14.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$59.6 million, marking a year-over-year change of. This contributed to the annual value of -$81.6 million for FY2024, which is 36.94% down from last year.
- Per Lexeo Therapeutics' latest filing, its Free Cash Flow stood at -$81.6 million for FY2024, which was down 36.94% from -$59.6 million recorded in FY2023.
- In the past 5 years, Lexeo Therapeutics' Free Cash Flow registered a high of -$55.2 million during FY2022, and its lowest value of -$81.6 million during FY2024.
- Over the past 3 years, Lexeo Therapeutics' median Free Cash Flow value was -$59.6 million (recorded in 2023), while the average stood at -$65.5 million.
- Data for Lexeo Therapeutics' Free Cash Flow shows a maximum YoY slumped of 36.94% (in 2024) over the last 5 years.
- Lexeo Therapeutics' Free Cash Flow (Yearly) stood at -$55.2 million in 2022, then dropped by 7.93% to -$59.6 million in 2023, then crashed by 36.94% to -$81.6 million in 2024.